Iridex Partners with EyeProGPO to Expand Retina Laser Access

The deal provides preferred pricing on Iridex's PASCAL, IQ, and OcuLight laser systems for EyeProGPO's 1,800+ member practices and facilities.

Apr. 8, 2026 at 6:04am

Got story updates? Submit your updates here. ›

A photorealistic studio still life of a sleek, modern retina laser device made of polished metal and glass, floating elegantly on a clean, monochromatic background and illuminated by dramatic studio lighting to conceptually represent the advanced technology and precision of Iridex's laser systems.Iridex's retina laser technology, now more accessible to ophthalmology practices through a new partnership with EyeProGPO.Mountain View Today

Iridex Corporation, a leader in laser-based medical systems for ophthalmology, has announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization. Through this deal, EyeProGPO's 1,800+ member practices, ambulatory surgery centers, and hospitals will receive preferred pricing on Iridex's PASCAL, IQ 532, IQ 577, and OcuLight TX retina laser platforms, helping to improve access to Iridex's proven technology.

Why it matters

The partnership aims to deliver both clinical and economic value to retina specialists and ophthalmic providers by combining Iridex's laser expertise with EyeProGPO's broad member network. It reflects Iridex's commitment to supporting physicians with reliable, clinically proven laser solutions while helping providers realize meaningful value through exclusive member pricing.

The details

Under the agreement, EyeProGPO members can access preferred pricing on Iridex's PASCAL laser platform, IQ 532 and IQ 577 lasers, and the OcuLight TX laser. This will help practices, ASCs, and hospitals improve access to Iridex's retina laser technology while supporting operational efficiency and value-based purchasing decisions.

  • The partnership was announced on April 7, 2026.

The players

Iridex Corporation

A worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases.

EyeProGPO

An ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery centers, and hospitals across the United States.

Phil Meyer

COO of EyeProGPO, LLC.

Patrick Mercer

President and CEO of Iridex.

Joan Stauffer

Media Contact at Iridex.

Got photos? Submit your photos here. ›

What they’re saying

“We are thrilled to partner with Iridex to bring their cutting-edge retina laser technology to our members. This partnership reflects our strong commitment to equipping our members with the latest advancements in eye care technology, enabling them to deliver the highest quality patient care.”

— Phil Meyer, COO of EyeProGPO, LLC

“We are excited to partner with EyeProGPO to extend broader access to Iridex retina laser technology across its growing network of ophthalmology practices, ASCs, and hospitals. The on-contract status reinforces the credibility of our technology and enables a more streamlined sales process for our team and customers. This partnership reflects our commitment to supporting physicians with reliable, clinically proven laser solutions while helping providers realize meaningful value through exclusive member pricing.”

— Patrick Mercer, President and CEO of Iridex

What’s next

The partnership is expected to expand the availability of Iridex's retina laser portfolio to EyeProGPO's growing network of ophthalmology practices, ASCs, and hospitals.

The takeaway

This partnership demonstrates Iridex's commitment to supporting ophthalmology providers with innovative, clinically proven laser technology while also helping them achieve operational and financial efficiencies through EyeProGPO's group purchasing model.